Dr. Ungewickell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Stanford Cancer Center
Palo Alto, CA 94304Phone+1 650-498-6000Fax+1 650-498-6205
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2009 - 2012
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2007 - 2010
- Washington University in St. Louis School of MedicineClass of 2007
Certifications & Licensure
- CA State Medical License 2008 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 42 citationsPhase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer.Daniel C. Danila, Russell Z. Szmulewitz, Ulka N. Vaishampayan, Celestia S. Higano, Ari David Baron
Journal of Clinical Oncology. 2019-11-05 - 135 citationsThe noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancerZurab Siprashvili, Dan E. Webster, Danielle Johnston, Rajani M Shenoy, Alexander Ungewickell
Nature Genetics. 2016-01-01 - 6 citationsThe HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.Gail D Lewis, Guangmin Li, Jun Guo, Shang-Fan Yu, Carter T Fields
Nature Communications. 2024-01-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: